MCY vs. BMY
Compare and contrast key facts about Mercury General Corporation (MCY) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MCY or BMY.
Correlation
The correlation between MCY and BMY is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MCY vs. BMY - Performance Comparison
Key characteristics
MCY:
0.75
BMY:
0.73
MCY:
1.18
BMY:
1.31
MCY:
1.18
BMY:
1.16
MCY:
0.76
BMY:
0.44
MCY:
2.52
BMY:
1.84
MCY:
12.05%
BMY:
11.51%
MCY:
40.76%
BMY:
29.02%
MCY:
-68.83%
BMY:
-70.62%
MCY:
-36.42%
BMY:
-22.92%
Fundamentals
MCY:
$2.83B
BMY:
$116.46B
MCY:
$9.88
BMY:
-$4.37
MCY:
1.19
BMY:
2.02
MCY:
$4.11B
BMY:
$35.96B
MCY:
$3.86B
BMY:
$24.67B
MCY:
$446.61M
BMY:
$605.00M
Returns By Period
In the year-to-date period, MCY achieves a -24.82% return, which is significantly lower than BMY's 1.62% return. Over the past 10 years, MCY has outperformed BMY with an annualized return of 3.90%, while BMY has yielded a comparatively lower 2.69% annualized return.
MCY
-24.82%
-17.66%
-16.46%
27.78%
4.70%
3.90%
BMY
1.62%
0.07%
24.40%
22.54%
0.55%
2.69%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MCY vs. BMY — Risk-Adjusted Performance Rank
MCY
BMY
MCY vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Mercury General Corporation (MCY) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MCY vs. BMY - Dividend Comparison
MCY's dividend yield for the trailing twelve months is around 2.55%, less than BMY's 4.26% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCY Mercury General Corporation | 2.55% | 1.91% | 3.41% | 5.57% | 4.78% | 4.83% | 5.16% | 4.84% | 4.67% | 4.12% | 5.31% | 4.35% |
BMY Bristol-Myers Squibb Company | 4.26% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% |
Drawdowns
MCY vs. BMY - Drawdown Comparison
The maximum MCY drawdown since its inception was -68.83%, roughly equal to the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for MCY and BMY. For additional features, visit the drawdowns tool.
Volatility
MCY vs. BMY - Volatility Comparison
Mercury General Corporation (MCY) has a higher volatility of 28.40% compared to Bristol-Myers Squibb Company (BMY) at 7.58%. This indicates that MCY's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MCY vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Mercury General Corporation and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities